Erasca (ERAS) had the lowest return in April 2026 by a mid-cap US stock, returning -35%.

ASSET	MONTH	% RETURN
Erasca (ERAS)	April 2026	-34.98%
Viridian Therapeutics (VRDN)	April 2026	-31.71%
Option Care Health (OPCH)	April 2026	-24.42%
Sportradar (SRAD)	April 2026	-22.28%
Badger Meter (BMI)	April 2026	-21.24%
Polibeli Group Ltd Class A Ordinary Shares (PLBL)	April 2026	-19.77%
Peabody Energy (BTU)	April 2026	-19.46%
Karman (KRMN)	April 2026	-18.66%
United States Lime & Minerals (USLM)	April 2026	-18.25%
MiniMed Group, Inc Common Stock (MMED)	April 2026	-18.17%
Insulet (PODD)	April 2026	-18.1%
Wix (WIX)	April 2026	-17.47%
Patrick Industries (PATK)	April 2026	-16.34%
EPAM Systems (EPAM)	April 2026	-15.98%
Pegasystems (PEGA)	April 2026	-15.33%
Comstock Resources (CRK)	April 2026	-14.61%
NovaGold Resources (NG)	April 2026	-14.35%
Appian (APPN)	April 2026	-14.16%
Vera Therapeutics (VERA)	April 2026	-14.15%
Qiagen (QGEN)	April 2026	-14.13%
Enphase Energy (ENPH)	April 2026	-13.78%
Laureate Education (LAUR)	April 2026	-13.64%
Eldorado Gold (EGO)	April 2026	-13.3%
Kratos Defense & Security Solutions (KTOS)	April 2026	-13.2%
Ideaya Biosciences (IDYA)	April 2026	-13.13%

Mid-cap stocks are treated as having a market cap between $2B and $10B.